NDC11 82381217401
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 82381-2174-01 | 82381-2174 |
| 82381-2174-1 | 82381-2174 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BRENZAVVY | BEXAGLIFLOZIN | TheracosBio, LLC | 3cdf28fc-4194-4ad6-aa03-c9eaa68da83e | 2026-06-10 | Warnings, Adverse reactions | 82381-2174-1 82381-2174 82381217401 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.